Pharmaceuticals
Pharmaceuticals covers the discovery, development, manufacturing and commercialization of prescription and over-the-counter drugs - small molecules, biologics, generics and biosimilars - across therapeutic areas, along with drug-delivery technologies and contract development and manufacturing. Markets are shaped by pipelines, patent cycles, pricing policy and regulation.
Strategic Research Scope & Methodological Coverage
How Credence Research isolates margin volatility, regulatory friction, and commercial scale across global drug manufacturing.
| Coverage Universe | Comprehensive volume, unit cost, and therapeutic market sizing across: Small Molecule Synthesis, Monoclonal Antibodies (mAbs), mRNA and Gene Therapies, Antibody-Drug Conjugates (ADCs), Biosimilar Formulations, and Sterile Injectable Fill-Finish operations. |
| Target Decision-Makers | Chief Commercial Officers, Heads of Global Sourcing, Portfolio Strategy Leads, CDMO Corporate Development Directors, and Healthcare Private Equity investment committees requiring independent asset due diligence. |
| Primary Value Proposition | Aggregated industry estimates mask clinical development attrition and yield failures. We measure the real economic impact of fermentation batch contamination, key starting material (KSM) price shocks, patent cliff erosion, and regional price-capping legislations. |
| Geographic Corridors | United States FDA cGMP manufacturing corridors, European EMA compliance centers, India API and generic manufacturing clusters (Gujarat, Telangana, Maharashtra), and Chinese chemical synthesis hubs under supply rebalancing. |
| Forecast Horizon | Dynamic 5- to 8-year capital expenditure and sales projection models (2026 to 2034) updated continuously through secondary patent tracking, clinical trial Phase readouts, and supplier audits. |
| Research Methodology | Direct primary engagements with CDMO plant managers, chemical synthesis procurement directors, pharmaceutical formulation scientists, and proprietary econometric pricing triangulation rather than recycled marketing summaries. |
Sector Taxonomy & Data Assets
Systematic analysis of active chemical entities, biologic yields, and contract manufacturing capacity.
| Vertical Sector | Primary Metric Tracked | Executive Buyer Strategic Focus | Credence Intelligence Deliverable |
|---|---|---|---|
| Small Molecule APIs | Batch synthesis yield, raw chemical precursor ASP | Continuous flow manufacturing, KSM nearshoring | Synthesis cost breakdown models, supply vulnerability scores |
| Biologics & Biosimilars | Grams-per-liter titer outputs, single-use run rates | Loss of exclusivity defensive plays, bioreactor scale | Bioreactor capacity mapping, patent cliff erosion curves |
| Sterile Injectables & Fill-Finish | Vials per minute throughput, cleanroom fill line loss | Aseptic barrier isolator adoption, syringe filling capacity | Fill-finish capacity databases, CDMO slot pricing forecasts |
| Antibody-Drug Conjugates (ADCs) | Linker-payload stability loss, batch cycle duration | High-potency API containment, targeted oncology pipeline | HPAPI facility utilization benchmarks, technology licensing analyses |
| Cell & Gene Therapies (CGT) | Autologous vein-to-vein turnaround time, viral vector titer | Scalable allogeneic platforms, viral vector yields | Cost-of-goods-sold (COGS) models, vector delivery valuations |
| Oral Solid Dosage (OSD) Formulations | Excipient pricing volatility, tablet press efficiency | Generic margin defense, high-potency oral containment | Commodity API margin compression tracking, country-level volumes |
Industrial Intelligence & Advisory Capabilities
Proprietary research modules and transaction support for pharmaceutical leaders.
Pharmaceuticals Market Snapshot
| Market | Base Size | Forecast | CAGR | Report |
|---|---|---|---|---|
| Bispecific Antibodies Market Size, Growth and Forecast 2032 | USD 5,740 million | USD 106,123.6 million | 44% | View → |
| India Anti-Obesity Drugs Market Size, Share and Forecast 2032 | USD 239.0 million | USD 3,451.1 million | 39.7% | View → |
| Postpartum Depression Market Size, Growth and Forecast 2032 | USD 68 million | USD 815.92 million | 36.50% | View → |
| Nonalcoholic Steatohepatitis Drugs Pipeline Market Size and Share 2032 | USD 272.25 million | USD 2746.74 million | 33.5% | View → |
| Urinary Tract Infection (UTI) Treatment Market Size & Growth 2032 | USD 9,400 million | USD 9,400 million | 29.70% | View → |
| Artificial Intelligence In Pharmaceutical Market Size and Forecast 2032 | USD 1750 million | USD 13528.67 million | 29.1% | View → |
| GMP Cell Therapy Consumables Market Size, Share and Forecast 2032 | USD 24.04 million | USD 172.15 million | 27.90% | View → |
| Cell and Gene Therapy Contract Development And Manufacturing Organization Market | USD 8,044 million | USD 44593.74 million | 27.72% | View → |
Featured Reports
Bispecific Antibodies Market Size, Growth and Forecast 2032
India Anti-Obesity Drugs Market Size, Share and Forecast 2032
Postpartum Depression Market Size, Growth and Forecast 2032
Nonalcoholic Steatohepatitis Drugs Pipeline Market Size and Share 2032
Urinary Tract Infection (UTI) Treatment Market Size & Growth 2032
Artificial Intelligence In Pharmaceutical Market Size and Forecast 2032
GMP Cell Therapy Consumables Market Size, Share and Forecast 2032
Cell and Gene Therapy Contract Development And Manufacturing Organization Market
Pharmaceuticals Reports
United States Specialty Pharmacy Market Size, Share, Growth and Forecast, 2025-2035
Orphan launches and the Part D cap lift United States specialty pharmacy revenue from USD 292.99 billion in 2025 to USD 625.11 billion by 2035, a 7.80% CAGR.
Cordyceps Militaris Market Size, Share, Growth and Forecast, 2025-2035
Cordyceps militaris market worth USD 1.63 billion in 2025 is forecast to reach USD 3.72 billion by 2035, at an 8.60% CAGR, led by China supply.
India Retail Pharmacy Market Size, Share, Growth and Forecast, 2025-2035
India retail pharmacy market worth USD 26.16 billion in 2025 is forecast to reach USD 63.08 billion by 2035, rising at a 9.20% CAGR as chains expand.
Asia-Pacific Radiopharmaceuticals Market Size, Share, Growth and Forecast, 2025-2035
Asia-Pacific radiopharmaceuticals market grows from USD 1.51 billion in 2025 to USD 5.40 billion by 2035 at a 13.56% CAGR as radioligand therapy spreads.
Asia-Pacific Dermatological Drugs Market Size, Share, Growth and Forecast, 2025-2035
Asia-Pacific dermatological drugs market rises from USD 10.22 billion in 2025 to USD 27.18 billion by 2035, at a 10.25% CAGR, as skin biologics gain coverage.
Australia Branded Generics Market Size, Share, Growth and Forecast, 2025-2035
Australia branded generics market worth USD 4.13 billion in 2025 reaches USD 7.60 billion by 2035 at a 6.25% CAGR, led by chronic refills and pharmacy brands.
Australia Emergency Contraceptive Pills Market Size, Share, Growth and Forecast, 2025-2035
Australia emergency contraceptive pills market worth USD 14.3 million in 2025 will reach USD 22.6 million by 2035 at a 4.66% CAGR as pharmacy access widens.
Australia Neuroendocrine Carcinoma Market Size, Share, Growth and Forecast, 2025-2035
Australia neuroendocrine carcinoma market worth USD 47.4 million in 2025 will reach USD 119.9 million by 2035 at a 9.73% CAGR as funded PRRT widens access.
Australia Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share, Growth and Forecast, 2025-2035
Outsourced gastroretentive drug delivery work in Australia grows from USD 39.1 million in 2025 to USD 79.2 million by 2035, a 7.30% CAGR, led by NSW and ACT.
Australia Gamma-Linolenic Acid Market Size, Share, Growth and Forecast, 2025-2035
Australia gamma-linolenic acid market worth USD 17.2 million in 2025 will reach USD 27.1 million by 2035 at a 4.66% CAGR as refills and online sales grow.
Australia Hyperhidrosis Treatment Market Size, Share, Growth and Forecast, 2025-2035
Funded toxin and a new PBS cream lift the Australia hyperhidrosis treatment market from USD 40.0 million in 2025 to USD 80.1 million by 2035.
Australia Non-Injectable Insulin Market Size, Share, Growth and Forecast, 2025-2035
Australia non-injectable insulin market worth USD 1.10 million in 2025 will reach USD 9.43 million by 2035 at a 24.00% CAGR as oral and inhaled formats advance.
Australia Nucleic Acid-Based Therapeutics Market Size, Share, Growth and Forecast, 2025-2035
Australia nucleic acid-based therapeutics market worth USD 360.0 million in 2025 will reach USD 1.55 billion by 2035 at a 15.72% CAGR as subsidy widens.
Dermatology Biologics Market Size, Share, Growth and Forecast, 2025-2035
Dermatology biologics market worth USD 31.60 billion in 2025 is forecast to reach USD 65.13 billion by 2035, rising at a 7.50% CAGR on new antibody approvals.
Urology Drugs Market Size, Share, Growth and Forecast, 2025-2035
Urology drugs market worth USD 29.09 billion in 2025 is forecast to reach USD 40.64 billion by 2035, rising at a 3.40% CAGR as prostate care expands.
Influenza Drugs Market Size, Share, Growth and Forecast, 2025-2035
Influenza drugs market worth USD 4.76 billion in 2025 is forecast to reach USD 9.14 billion by 2035, rising at a 6.74% CAGR as severe seasons lift treatment.
Multiple Sclerosis Drugs Market Size, Share, Growth and Forecast, 2025-2035
Multiple sclerosis drugs market worth USD 25.92 billion in 2025 is forecast to reach USD 40.25 billion by 2035 at a 4.50% CAGR as B-cell therapies spread.
Smoking Cessation Drugs Market Size, Share, Growth and Forecast, 2025-2035
Smoking cessation drugs market worth USD 1.86 billion in 2025 is forecast to reach USD 3.50 billion by 2035 at a 6.52% CAGR as quit access widens.
Biosimilars Market Size, Share, Growth and Forecast, 2025-2035
Biosimilars market worth USD 31.01 billion in 2025 is forecast to reach USD 85.07 billion by 2035 at a 10.62% CAGR, as antibody patents expire.
Respiratory Drugs Market Size, Share, Growth and Forecast, 2025-2035
Respiratory drugs market worth USD 43.11 billion in 2025 is set to reach USD 73.43 billion by 2035 at a 5.47% CAGR as asthma and COPD biologics expand.
Australia Generic Pharmaceuticals Market Size, Share, Growth and Forecast, 2025-2035
Australia generic pharmaceuticals market worth USD 4.32 billion in 2025 reaches USD 5.98 billion by 2035 at a 3.28% CAGR on biosimilar uptake and PBS reform.
Women's Health Drugs Market Size, Share, Growth and Forecast, 2025-2035
Women's health drugs market worth USD 47.24 billion in 2025 is set to reach USD 79.22 billion by 2035 at a 5.31% CAGR as menopause and bone care expand.
Transdermal Drugs Market Size, Share, Growth and Forecast, 2025-2035
Transdermal drugs market worth USD 6.84 billion in 2025 is set to reach USD 12.84 billion by 2035 at a 6.51% CAGR as patch therapy grows in pain and hormones.
Vaccines Market Size, Share, Growth and Forecast, 2025-2035
Vaccines market worth USD 75.45 billion in 2025 is forecast to reach USD 151.20 billion by 2035, rising at a 7.20% CAGR as adult immunization expands.
Built for Decision-Makers
B2B clients served worldwide
Market research reports published
Of Fortune 1,000 companies as clients
Forecast horizon in every report
Frequently Asked Questions
Need a Custom Pharmaceuticals Market Study?
Get a free sample report or speak with a research analyst about your specific segment or region.